This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (70) Citing Articles via Google Scholar Google Scholar Articles by Wu, A. H. Articles by Koelling, T. M. Search for Related Content PubMed PubMed Citation Articles by Wu, A. H. Articles by Koelling, T. M.

Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction

Audrey H. Wu, MD, MPH^*, Keith D. Aaronson, MD, MS^*, Steven F. Bolling, MD, FACC, Francis D. Pagani, MD, PhD, FACC, Kathy Welch, MS, MPH and Todd M. Koelling, MD, FACC^*,*

^* Division of Cardiology, Department of Internal Medicine
Section of Cardiac Surgery, Department of Surgery
Center for Statistical Consultation and Research, University of Michigan Health Systems, Ann Arbor, Michigan.

View larger version (13K): [in a new window]   Figure 1 Event-free survival for non-mitral-valve annuloplasty (MVA) group (solid line) and MVA group (dotted line).

View larger version (13K): [in a new window]   Figure 2 Event-free survival for patients without coronary artery disease in non-mitral-valve annuloplasty (MVA) group (solid line) and MVA group (dotted line).